Sale!

ACP5 Gene Spondyloenchondrodysplasia with Immune Dysregulation Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ACP5 gene test for Spondyloenchondrodysplasia with Immune Dysregulation is a specialized genetic examination offered by DNA Labs UAE. This test focuses on identifying mutations in the ACP5 gene, which are associated with spondyloenchondrodysplasia, a rare skeletal dysplasia characterized by vertebral and metaphyseal abnormalities alongside immune system dysregulation. This condition can lead to various clinical manifestations, including short stature, spinal abnormalities, and increased susceptibility to autoimmune disorders.

DNA Labs UAE provides this comprehensive genetic test at a cost of 4400 AED. The test is designed to offer crucial insights for individuals presenting symptoms of this disorder, enabling targeted management and treatment strategies. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic mutations in the ACP5 gene. The results can assist healthcare providers in confirming a diagnosis, understanding the disease’s progression, and implementing appropriate therapeutic interventions. Given the complexity of spondyloenchondrodysplasia with immune dysregulation, this genetic test is a valuable tool for affected individuals and their families, offering hope for improved outcomes through personalized medicine.

Description

ACP5 Gene Spondyloenchondrodysplasia with immune dysregulation Genetic Test

Test Name: ACP5 Gene Spondyloenchondrodysplasia with immune dysregulation Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ACP5 Gene Spondyloenchondrodysplasia with immune dysregulation NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ACP5 Gene Spondyloenchondrodysplasia with immune dysregulation NGS Genetic DNA Test gene ACP5

Test Details: The ACP5 gene is associated with a rare genetic disorder called spondyloenchondrodysplasia with immune dysregulation (SPENCDI). This disorder is characterized by skeletal abnormalities, immune system dysfunction, and other features. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup. In the context of SPENCDI, NGS genetic testing can be used to identify mutations or variations in the ACP5 gene, which can help confirm a diagnosis of SPENCDI. Genetic testing for SPENCDI can be beneficial for individuals with suspected or confirmed symptoms of the disorder, as it can provide valuable information for diagnosis, prognosis, and genetic counseling. It can also help guide treatment decisions and provide insights into potential complications or associated conditions. It is important to consult with a healthcare professional or genetic counselor to determine if NGS genetic testing is appropriate for an individual suspected of having SPENCDI. They can provide guidance on the benefits, limitations, and potential risks associated with genetic testing, as well as help interpret the results.

Test Name	ACP5 Gene Spondyloenchondrodysplasia with immune dysregulation Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ACP5 Gene Spondyloenchondrodysplasia with immune dysregulation NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ACP5 Gene Spondyloenchondrodysplasia with immune dysregulation NGS Genetic DNA Test gene ACP5
Test Details	The ACP5 gene is associated with a rare genetic disorder called spondyloenchondrodysplasia with immune dysregulation (SPENCDI). This disorder is characterized by skeletal abnormalities, immune system dysfunction, and other features. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup. In the context of SPENCDI, NGS genetic testing can be used to identify mutations or variations in the ACP5 gene, which can help confirm a diagnosis of SPENCDI. Genetic testing for SPENCDI can be beneficial for individuals with suspected or confirmed symptoms of the disorder, as it can provide valuable information for diagnosis, prognosis, and genetic counseling. It can also help guide treatment decisions and provide insights into potential complications or associated conditions. It is important to consult with a healthcare professional or genetic counselor to determine if NGS genetic testing is appropriate for an individual suspected of having SPENCDI. They can provide guidance on the benefits, limitations, and potential risks associated with genetic testing, as well as help interpret the results.